Tag: Cancer: Esophageal
Guideline Updated for Screening, Surveillance of Barrett Esophagus
Chromoendoscopy strongly recommended for patients with Barrett esophagus undergoing surveillance
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
Adenocarcinoma, High-Grade Dysplasia Up With Barrett Esophagus
But Barrett esophagus length has decreased, as has prevalence of low-grade dysplasia on endoscopy
Sponge Cytology-Sampling Device Promising for Barrett Esophagus Dx
Swallowable sampling device combined with methylation biomarker panel IDs Barrett esophagus
Fewer Complications Found With Hybrid Surgery for Esophageal Cancer
Incidence of intraoperative, postoperative complications lower in resectable esophageal cancer
Head and Neck Cancer Survivors Have Increased Suicide Risk
Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers
Pembrolizumab Not Better Than PTX for Advanced Gastric Cancer
Survival no better with second-line pembrolizumab than paclitaxel for gastric, gastro-esophageal cancer
Breath Test Shows Promise for Diagnosis of Esophagogastric CA
Good diagnostic accuracy with area under the curve of 0.85, sensitivity and specificity of 80, 81 percent
Nodal Response to Pre-Op Tx Tied to Survival in Esophageal Cancer
Survival benefit of nodal response maintained among patients with nodal, but not primary response
